Eleven Biotherapeutics Lands $20,000,010 New Financing Round

  • Feed Type
  • Date
  • Company Name
    Eleven Biotherapeutics
  • Mailing Address
    215 First Street Cambridge, MA 02142 USA
  • Company Description
    Eleven Biotherapeutics (NASDAQ: EBIO) uses its proprietary technology platform to create first-of-a-kind protein therapeutics to treat ocular diseases in new and effective ways.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy